Table 1.
Risk | High | Low | p-Value 1 |
---|---|---|---|
n = 11 | n = 13 | ||
Age at diagnosis | 65.5 ± 4.1 | 59.4 ± 10.5 | 0.006 |
PSA | 8.3 ± 6.59 | 9.23 ± 9.33 | 0.350 |
Vital status | 0.500 | ||
Deceased | 1 | 0 | |
Alive | 10 | 11 | |
Missing | 0 | 2 | |
Gleason score | <0.0001 | ||
6 | 0 | 8 | |
7 (3 + 4) | 0 | 5 | |
7 (4 + 3) | 7 | 0 | |
8–9 | 4 | 0 | |
Biochemical recurrence (BCR) | 0.160 | ||
Yes | 3 | 1 | |
No | 7 | 12 | |
Missing | 1 | 0 | |
Clinical Stage | 0.330 | ||
T2a | 1 | 3 | |
T2c | 6 | 9 | |
T3a | 1 | 0 | |
T3b | 3 | 1 | |
Surgical margins | 0.480 | ||
Yes | 1 | 0 | |
No | 8 | 11 | |
Missing | 2 | 2 | |
Family history of prostate cancer | 0.830 | ||
No | 3 | 5 | |
Yes | 3 | 3 | |
Missing | 5 | 5 |
1p-Values were obtained from Student’s t, chi-square, or Fisher exact tests. PSA, prostate-specific antigen.